Dec 19, 2017 Challenging Statistics By Kate Hodgkiss The most likely explanation for the anomalies identified in the gender pay reports published so far is the fact that, whilst...
Dec 11, 2017 Personal Data - Extending Liability By Kate Hodgkiss At a time when organisations are looking to put their houses in order to address the demands of GDPR, this poses a salutary warning to...
Dec 08, 2017 FDA and the Future of Digital Health By Becca McKnight New guidance just out from FDA on its approach to the regulation of digital health. For companies pursuing opportunities where...
Dec 01, 2017 Crispr - a fascinating new technology on the horizon of mankind. By Bertold Bar-Bouyssiere This is intriguing and may be the 3D-printer of the life science industry. Obviously, there are many legal pitfalls that require careful...
Dec 01, 2017 Lawyers plan too. By Mark Franklin Sitting with the German DLA Piper Life Science team, my language skills being push to the limit I am reminded of Dan Connors, Applied...
Nov 30, 2017 Ask a GDPR expert at Pharma Lawconvention, Berlin. By Mark Franklin I've spent the last 2 days listening to experts on GDPR in the Life Science industry. There are about 120 working days until this...
Nov 29, 2017 Livia Zamfiropol speaks at Pharma lawconvention of GDPR By Mark Franklin A number of GDPR experts from pharma companies gathered in Berlin to discuss data privacy and GDPR. Livia Zamfiropol (DLA Piper partner)...
Nov 17, 2017 Checkpoint Inhibitors and Diabetes By Lisa Haile PD-L1 and checkpoint inhibitors have been front and center in the media relating to the treatment of cancer. Researches are now looking...
Nov 17, 2017 Regulating High Cholesterol-A Never Ending Challenge By Lisa Haile Researchers from Harvard identified a new protein, Nrf1, which regulates high cholesterol by binding directly to it. This binding prompts...
Nov 17, 2017 Human Embryonic Stem Cells to Treat Blindness By Lisa Haile We have been hearing for a decade about the use of stem cells to create organs and treat diseases. Today, a study showing that hES cells...
Nov 15, 2017 Roche's Alecensa for Lung Cancer Gets a Nod from the FDA By Lisa Haile Roche's Alecensa, a drug for treatment of ALK positive lung cancer, has received a nod from the FDA. While only 5% of lung cancer...
Nov 14, 2017 Sanofi Enters the Race to Develop a New Drug for Multiple Sclerosis By Lisa Haile Sanofi has paid big bucks to enter the race to develop a new drug for MS. The drug was developed by Principia Biopharma and crosses the...
Nov 10, 2017 Transparency in Pay By Kate Hodgkiss In sectors where male employees hold the most senior jobs, and women are under-represented at all levels, the Gender Pay Gap Reports may...
Nov 10, 2017 Glacial progress or on the point of change? By Kate Hodgkiss The fact that this day remains unchanged from last year confirms that the pace of change has been ... rather less than "pacey". I will...
Nov 10, 2017 Flexibility and expertise combined By Kate Hodgkiss Interesting article about fledgling creative ways of enabling tomorrow's employees acquire the hands- on practical experience and skills...
Nov 10, 2017 Medical devices and the smartphone's growing influence By DLA Piper Like many, I love finding out about how technology is shaping our lives and changing society. Deloitte's new research on smartphones...